apo-risedronate risedronate sodium 150 mg tablets blister pack
arrotex pharmaceuticals pty ltd - risedronate sodium hemipentahydrate, quantity: 173.4 mg - tablet, film coated - excipient ingredients: hypromellose; magnesium stearate; crospovidone; titanium dioxide; hyprolose; colloidal anhydrous silica; macrogol 8000; lactose; monobasic sodium phosphate dihydrate; dibasic sodium phosphate; indigo carmine aluminium lake; monobasic sodium phosphate monohydrate - the treatment of osteoporosis,the treatment of glucocorticoid-induced osteoporosis,the preservation of bone-mineral density in patients on long term corticosteroid therapy
apo-risedronate risedronate sodium (as hemipentahydrate) 35 mg tablet blister pack
arrotex pharmaceuticals pty ltd - risedronate sodium hemipentahydrate, quantity: 40.5 mg (equivalent: risedronate sodium, qty 35 mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; iron oxide red; macrogol 8000; magnesium stearate; hyprolose; lactose; titanium dioxide; hypromellose; crospovidone; iron oxide yellow - - treatment of osteoporosis. - treatment of glucocorticoid-induced osteoporosis. - preservation of bone mineral density in patients on long term corticosteroid therapy.
apo-risedronate risedronate sodium 75mg tablets bottle
arrotex pharmaceuticals pty ltd - risedronate sodium hemipentahydrate, quantity: 86.7 mg - tablet, film coated - excipient ingredients: hypromellose; titanium dioxide; macrogol 8000; iron oxide red; colloidal anhydrous silica; hyprolose; magnesium stearate; crospovidone; lactose - the treatment of osteoporosis,the treatment of glucocorticoid-induced osteoporosis,the preservation of bone-mineral density in patients on long term corticosteroid therapy
apo-risedronate risedronate sodium 75mg film coated tablets blister pack
arrotex pharmaceuticals pty ltd - risedronate sodium hemipentahydrate, quantity: 86.7 mg - tablet, film coated - excipient ingredients: hyprolose; iron oxide red; colloidal anhydrous silica; magnesium stearate; hypromellose; macrogol 8000; crospovidone; titanium dioxide; lactose - the treatment of osteoporosis,the treatment of glucocorticoid-induced osteoporosis,the preservation of bone-mineral density in patients on long term corticosteroid therapy
apo-risedronate risedronate sodium (as hemipentahydrate) 35 mg tablet bottle
arrotex pharmaceuticals pty ltd - risedronate sodium hemipentahydrate, quantity: 40.5 mg (equivalent: risedronate sodium, qty 35 mg) - tablet, film coated - excipient ingredients: hypromellose; titanium dioxide; macrogol 8000; lactose; magnesium stearate; iron oxide red; crospovidone; hyprolose; colloidal anhydrous silica; iron oxide yellow - - treatment of osteoporosis. - treatment of glucocorticoid-induced osteoporosis. - preservation of bone mineral density in patients on long term corticosteroid therapy.
risedronate sodium- risedronate sodium tablet, film coated
mylan pharmaceuticals inc. - risedronate sodium (unii: ofg5exg60l) (risedronic acid - unii:km2z91756z) - risedronate sodium 5 mg - risedronate sodium tablets are indicated for the treatment and prevention of osteoporosis in postmenopausal women. in postmenopausal women with osteoporosis, risedronate reduces the incidence of vertebral fractures and a composite endpoint of nonvertebral osteoporosis-related fractures [see clinical studies (14.1, 14.2) ]. risedronate sodium tablets are indicated for treatment to increase bone mass in men with osteoporosis. risedronate sodium tablets are indicated for the treatment and prevention of glucocorticoid-induced osteoporosis in men and women who are either initiating or continuing systemic glucocorticoid treatment (daily dosage of greater than or equal to 7.5 mg of prednisone or equivalent) for chronic diseases. patients treated with glucocorticoids should receive adequate amounts of calcium and vitamin d. risedronate sodium tablets are indicated for treatment of paget’s disease of bone in men and women. the optimal duration of use has not been determined. the safety and effectiveness of risedronate
apo-risedronate tablet
apotex inc - risedronate sodium (risedronate sodium hemipentahydrate) - tablet - 150mg - risedronate sodium (risedronate sodium hemipentahydrate) 150mg - bone resorption inhibitors
pms-risedronate tablet
pharmascience inc - risedronate sodium (risedronate sodium hemipentahydrate) - tablet - 35mg - risedronate sodium (risedronate sodium hemipentahydrate) 35mg - bone resorption inhibitors
apo-risedronate tablet
apotex inc - risedronate sodium (risedronate sodium hemipentahydrate) - tablet - 35mg - risedronate sodium (risedronate sodium hemipentahydrate) 35mg - bone resorption inhibitors
pms-risedronate tablet
pharmascience inc - risedronate sodium (risedronate sodium hemipentahydrate) - tablet - 150mg - risedronate sodium (risedronate sodium hemipentahydrate) 150mg - bone resorption inhibitors